These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1535654)

  • 21. A potential role for angiotensin II-induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy?
    Williams B
    Miner Electrolyte Metab; 1998; 24(6):400-5. PubMed ID: 9930379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glomerular hemodynamic and structural alterations in experimental diabetes mellitus.
    O'Donnell MP; Kasiske BL; Keane WF
    FASEB J; 1988 May; 2(8):2339-47. PubMed ID: 3282959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete remission of diabetic nephropathy in a type 1 diabetic patient with near-nephrotic range proteinuria and reduced renal function.
    Haraguchi K; Hara S; Ubara Y; Tanaka S; Nukui I; Shimura H; Ohashi K; Kobayashi T
    Diabetes Res Clin Pract; 2009 Mar; 83(3):295-9. PubMed ID: 19162360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glomerular hyperfiltration in essential hypertension: hormonal aspects.
    Regolisti G; Buzio C; Cavatorta A; De Martin L; Cavalli R; Perazzoli F; Coghi P; Cabassi A; Pucci F; Borghetti A
    Acta Biomed Ateneo Parmense; 1992; 63(1-2):163-73. PubMed ID: 1340661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular growth factors and the development of macrovascular disease in diabetes mellitus.
    Koschinsky T; Bünting CE; Rütter R; Gries FA
    Diabete Metab; 1987 Jul; 13(3 Pt 2):318-25. PubMed ID: 3308559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis.
    Doi T; Striker LJ; Gibson CC; Agodoa LY; Brinster RL; Striker GE
    Am J Pathol; 1990 Sep; 137(3):541-52. PubMed ID: 2399934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy.
    Uehara G; Suzuki D; Toyoda M; Umezono T; Sakai H
    Clin Exp Nephrol; 2004 Mar; 8(1):36-42. PubMed ID: 15067514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of angiotensin II in diabetic nephropathy.
    Kennefick TM; Anderson S
    Semin Nephrol; 1997 Sep; 17(5):441-7. PubMed ID: 9316212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An overview of renal pathology in insulin-dependent diabetes mellitus in relationship to altered glomerular hemodynamics.
    Fioretto P; Steffes MW; Brown DM; Mauer SM
    Am J Kidney Dis; 1992 Dec; 20(6):549-58. PubMed ID: 1462981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
    Wang SN; LaPage J; Hirschberg R
    Kidney Int; 2000 Mar; 57(3):1002-14. PubMed ID: 10720953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SGLT2 Inhibitors and the Diabetic Kidney.
    Fioretto P; Zambon A; Rossato M; Busetto L; Vettor R
    Diabetes Care; 2016 Aug; 39 Suppl 2():S165-71. PubMed ID: 27440829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glomerular hyperfiltration in insulin-dependent diabetes mellitus is correlated with enhanced growth hormone secretion.
    Blankestijn PJ; Derkx FH; Birkenhäger JC; Lamberts SW; Mulder P; Verschoor L; Schalekamp MA; Weber RF
    J Clin Endocrinol Metab; 1993 Aug; 77(2):498-502. PubMed ID: 8345058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel somatostatin analogue prevents early renal complications in the nonobese diabetic mouse.
    Landau D; Segev Y; Afargan M; Silbergeld A; Katchko L; Podshyvalov A; Phillip M
    Kidney Int; 2001 Aug; 60(2):505-12. PubMed ID: 11473633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the JAK/STAT signaling pathway in diabetic nephropathy.
    Marrero MB; Banes-Berceli AK; Stern DM; Eaton DC
    Am J Physiol Renal Physiol; 2006 Apr; 290(4):F762-8. PubMed ID: 16527921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlations of tissue macrophages and cytoskeletal protein expression with renal fibrosis in patients with diabetes mellitus.
    Yonemoto S; Machiguchi T; Nomura K; Minakata T; Nanno M; Yoshida H
    Clin Exp Nephrol; 2006 Sep; 10(3):186-92. PubMed ID: 17009076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of transforming growth factor-beta in regulation of calcium transients in diabetic vascular smooth muscle cells.
    Sharma K; Deelman L; Madesh M; Kurz B; Ciccone E; Siva S; Hu T; Zhu Y; Wang L; Henning R; Ma X; Hajnoczky G
    Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1258-70. PubMed ID: 12876066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology.
    Wolf G
    Eur J Clin Invest; 2004 Dec; 34(12):785-96. PubMed ID: 15606719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The renal hemodynamic basis of diabetic nephropathy.
    O'Bryan GT; Hostetter TH
    Semin Nephrol; 1997 Mar; 17(2):93-100. PubMed ID: 9148381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.